- A new, more targeted radiotherapy treatment for low-risk breast cancer has been adopted by the NHS, aiming to reduce debilitating side effects.
- The Import Low trial, involving over 2,000 women, demonstrated that limiting radiation to the tumour area is as effective as treating the whole breast in preventing cancer recurrence over a decade.
- Patients undergoing this partial-breast radiotherapy experienced significantly fewer side effects and changes in breast appearance compared to those receiving whole-breast treatment.
- Researchers from The Institute of Cancer Research and the University of Cambridge led the study, which has "transformed" the approach to early breast cancer treatment.
- This new method is now integrated into NHS treatment guidelines and informs international practices, with over 9,000 women in the UK potentially benefiting.
IN FULL
